ENPP1 and obesity due to melanocortin 4 receptor deficiency: In the present study we have examined the full impact of chronic suppression of NPP1 and provide new evidence demonstrating that ablation of the bone mineralization inhibitor NPP1 protects against insulin resistance, obesity and diabetes.